Jean-Baptiste Bachet (Jean Baptiste Bachet)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Positron Emission Tomography

Metastatic Colorectal Cancer

Contrast Enhanced

Top Venues

World journal of surgical oncology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Emeric Boisteau, Laetitia Dahan, Nicolas Williet, Karine Le Malicot, Jérôme Desramé, Olivier Bouché, Caroline Petorin, David Malka, Christine Rebischung, Thomas Aparicio, Cédric Lecaille, Yves Rinaldi, Anthony Turpin, Anne-Laure Bignon, Jean-Baptiste Bachet, Côme Lepage, Victoire Granger, Jean-Louis Legoux, Gaël Deplanque, Mathieu Baconnier, Thierry Lecomte, Isabelle Bonnet, Jean-François Seitz, Eric François, Astrid Lièvre, null null
Clinico-biological factors predicting the benefit of the LV5FU2 maintenance strategy as a first-line therapy in patients with metastatic pancreatic cancer. The oncologist (2024)
Charlie Saillard, Flore Delecourt, Benoit Schmauch, Olivier Moindrot, Magali Svrcek, Armelle Bardier-Dupas, Jean François Emile, Mira Ayadi, Vinciane Rebours, Louis de Mestier, Pascal Hammel, Cindy Neuzillet, Jean-Baptiste Bachet, Juan Lucio Iovanna, Nelson J Dusetti, Yuna Blum, Magali Richard, Yasmina Kermezli, Valerie Paradis, Mikhail Zaslavskiy, Pierre Courtiol, Aurélie Kamoun, Remy Nicolle, Jerome Cros
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma. Nature communications 14 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Gilles Manceau, Timothy Jay Price, Loïck Vidot, Bénédicte Chevallier, Lucjan Wyrwicz, Jean-Baptiste Bachet
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy. BMC cancer 23 (1) (2023)
Sahir Javed, Stéphane Benoist, Patrick Devos, Stéphanie Truant, Rosine Guimbaud, Astrid Lièvre, David Sefrioui, Romain Cohen, Pascal Artru, Aurélien Dupré, Jean-Baptiste Bachet, Christelle De La Fouchardière, Anne Ploquin, Anthony Turpin
Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study. World journal of surgical oncology 20 (1) (2022)
Clémence Canton, Olayidé Boussari, Mathieu Boulin, Karine Le Malicot, Gilles Manceau, Laetitia Dahan, Anthony Lopez, Come Lepage, Jean-Baptiste Bachet
Impact of G-CSF Prophylaxis on Chemotherapy Dose-Intensity, Link Between Dose-Intensity and Survival in Patients with Metastatic Pancreatic Adenocarcinoma. The oncologist 27 (7) (2022)